Atai stock forecast.

LPTX Stock 12 Months Forecast. Based on 3 Wall Street analysts offering 12 month price targets for Leap Therapeutics in the last 3 months. The average price target is $10.00 with a high forecast of $12.00 and a low forecast of $7.00. The average price target represents a 249.65% change from the last price of $2.86.Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...-15.00(-0.11%) Russell 2000 1,807.50 +11.96(+0.67%) Crude Oil 75.54 -1.56(-2.02%) Gold 2,003.00 +10.20(+0.51%) Atai Life Sciences N.V. (ATAI) NasdaqGM - NasdaqGM Real Time Price. Currency in...ATAI / ATAI Life Sciences N.V. - Forecast and Price Target https://fintel.io/sfo/us/atai. See More. Bullish. Reply. Keep. Last Read. Share. Copy Message ...

13. 1. 2023. ... atai Life Sciences Founder Christian Angermayer explains that all will ... Stock Market Sectors You Like 32:39 - 33:42 Optimism For Industry ...

Atai Life Sciences N.V. (ATAI.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atai Life Sciences N.V. | Nasdaq: ...

Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for ATAI stock stock is $13.5, which predicts an increase of 1,138.53%. The lowest target is $9.00 and the highest is $20. On average, analysts rate ATAI stock stock as a strong buy.ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary.What is the current Price Target and Forecast for atai Life Sciences (ATAI) atai Life Sciences (ATAI) (Real Time Quote from BATS) $1.10 USD 0.00 (0.00%) Updated Nov 27, 2023 10:58 AM ET...U.S. Television Show Ratings Ranking. Ranking is based on ratings data as of Monday, November 20, 2023. The audience figures are derived from the latest Nielsen daily, weekly, or monthly P2+ program audience averages, whichever is the most recently available within the past seven-day window.

Meanwhile, Atai listed on the Nasdaq in June, raising $225 million at a valuation of $2.3 billion. The stock immediately popped 40% but it has since halved in value and Atai's current market cap ...

Jun 15, 2021 · Since Atai Life Sciences is only going public, we don’t have any forecast for the stock. Also, being a clinical-stage company, we don’t have earnings-based metrics to value the stock.

Find the latest SoundHound AI, Inc. (SOUN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Nov 24, 2023 · NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here. Are investors shorting NeuBase Therapeutics? NeuBase Therapeutics saw a decrease in short interest in the month of October. Aug 14, 2023 · Atai Life Sciences is forecasted to grow earnings and revenue by 20.7% and 73.6% per annum respectively. EPS is expected to grow by 29.2%. Return on equity is forecast to be -69.3% in 3 years. Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00.As such, ATAI has been trading -1490.91% off suggested target high and -286.36% from its likely low. ATAI Life Sciences N.V. (ATAI) estimates and forecasts. Looking at statistics comparing ATAI Life Sciences N.V. share performance against respective industry, we note that the company has outperformed competitors.Dividend History. Dividend Yield Chart. Learn more about Atai Life Sciences's (ATAI) dividend history, ex-dividend date, and yield. Zacks.com Our Research, Your Success.

Some better-ranked stocks in the broader Medical space are Select Medical Holdings Corporation SEM, HCA Healthcare, Inc. HCA and Atai Life Sciences N.V. ATAI, each carrying a Zacks Rank #2 (Buy ...Economies.com provides you with ATA Inc share price (ATAI) listed in the stock exchange, including the low, high, opening and closing price.When is Atai Life Sciences's earnings date? Atai Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 22nd, 2024 based off last year's report dates. Learn more on ATAI's earnings history.We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...EOSE Stock 12 Months Forecast. $10.50. (845.95% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Eos Energy Enterprises in the last 3 months. The average price target is $10.50 with a high forecast of $17.00 and a low forecast of $2.00. The average price target represents a 845.95% change from the last price of $1.11.

NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here. Are investors shorting NeuBase Therapeutics? NeuBase Therapeutics saw a decrease in short interest in the month of October.

Dec 1, 2023 · See the latest ATAI Life Sciences NV stock price (ATAI:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Nov 29, 2023 · Atai Life Sciences Stock Price, News & Analysis (NASDAQ:ATAI) $1.10 +0.01 (+0.92%) (As of 11/24/2023 ET) Compare Today's Range $1.08 $1.12 50-Day Range $1.06 $1.52 52-Week Range $1.05 $3.65 Volume 272,978 shs Average Volume 997,775 shs Market Capitalization $182.61 million P/E Ratio N/A Dividend Yield N/A Price Target $12.80 28.98. According to our current ATAI stock forecast, the value of Atai Life Sciences N.V. shares will drop by -18.90% and reach $ 0.875911 per share by December 3, 2023. …WebStock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00.Atai Life Sciences N.V. (ATAI) Stock Price, Quote & News - Stock Analysis 1.12 -0.02 (-2.19%) Nov 29, 2023, 10:07 AM EST - Market Overview Financials Statistics …WebOn December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until the 2024 annual meeting of the Company’s stockholders, or until their respective successors are duly elected and qualified.Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Digital Turbine Inc have a median target of 5.50, with a high estimate of 12.00 and a low estimate of 5.00. The median ...Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Somalogic Inc have a median target of 4.75, with a high estimate of 7.00 and a low estimate of 2.30. The median estimate ...

Find real-time DNUT - Krispy Kreme Inc stock quotes, company profile, news and forecasts from CNN Business.

Find latest ATAI Life Sciences N.V. (ATAI) stock discussions and message board on Twitter, StocksTwits, Reddit, SeekingAlpha and other social media. Stock Screener App. Free - Install. Dark EN. Sign in. ... Discussions Forecast. ATAI Life Sciences N.V. (ATAI) Stock Discussion & Message Board

Find the latest Applied Digital Corporation (APLD) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...ATAI Life Sciences N.V. Stock Chart and Share Price Forecast, Short-Term "ATAI" Stock Prediction for Next Days and Weeks Walletinvestor.com ATAI Life Sciences N.V. (ATAI) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 According to TipRanks, Palomeque has an average return of -14.1% and a 28.57% success rate on recommended stocks. Currently, the analyst consensus on ATAI Life Sciences is a Strong Buy with an average price target of $13.75.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $4.96 and a one-year low of $1.14. Sep 30, 2023.View a financial market summary for ATAI including stock price quote, trading volume, volatility, options volume, statistics, and other important company ...Nov 24, 2023 · NeuBase Therapeutics' stock was trading at $3.8040 on January 1st, 2023. Since then, NBSE stock has decreased by 82.2% and is now trading at $0.6758. View the best growth stocks for 2023 here. Are investors shorting NeuBase Therapeutics? NeuBase Therapeutics saw a decrease in short interest in the month of October. Stock analysis for ATAI Life Sciences NV (ATAI:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.NEW YORK and BERLIN, Aug. 10, 2023-- atai Life Sciences, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, reported second quarter 2023 ...What is the current Price Target and Forecast for atai Life Sciences (ATAI) atai Life Sciences (ATAI) (Real Time Quote from BATS) $1.10 USD 0.00 (0.00%) Updated Nov 27, 2023 10:58 AM ET...

atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of ...Even in a speculative industry, I believe the stock is undervalued by these few facts alone. ATAI holds: 450M cash and cash equivalents; 20% equity stake in CMPS (750M mktcp - 150M worth at current prices); and ATAI has a vast ip pipeline that includes 9 lead compounds. Curious as to the community’s thoughts here!NEW YORK and BERLIN, Sept. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 Cantor Fitzgerald Global Healthcare Conference. September 14, 2023. Press Release.Instagram:https://instagram. non conforming lenderslong term treasury etfbfacdental plans washington 3:24 pm. Articles. atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine) August 10, 2023 Advanced multiple clinical stage assets in development, including the on-going Phase 2b study of RL-007 in patients…. August 10, 2023. gas and oil etfwilmar Atai Capital experienced a decline of 5.8% in the third quarter, bringing our year-to-date (YTD) returns to 6.5% net of all fees. This compares to a 13.1% total return for the S&P 500 YTD and a 2. ... how to start trading forex Exela Technologies Inc () Stock Market info Recommendations: Buy or sell Exela Technologies stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Exela Technologies share forecasts, stock quote and buy / sell signals below.According to present data Exela Technologies's XELA shares and potentially its …Atari S.A. is an interactive entertainment company and an iconic gaming industry brand that transcends generations and audiences. The company is globally recognized for its multi-platform, interactive entertainment and licensed products.SVRA Stock 12 Months Forecast. $6.67. (79.30% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Savara in the last 3 months. The average price target is $6.67 with a high forecast of $7.00 and a low forecast of $6.00. The average price target represents a 79.30% change from the last price of $3.72.